AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Serco Group PLC

Share Issue/Capital Change Apr 1, 2020

5273_rns_2020-04-01_bf35a8a9-e8da-4ca4-bd0f-a45b6824ca00.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4092I

Serco Group PLC

01 April 2020

1 April 2020

Serco Group plc

LEI: 549300PT2CIHYN5GWJ21

Issue of shares to Employee Share Ownership Trust

Serco Group plc (the "Company") has applied to the FCA and the London Stock Exchange for the listing of an additional 10,000,000 ordinary shares of 2 pence each in the Company ("Ordinary Shares") to trade on the London Stock Exchange and to be admitted to the FCA's Official List. The Ordinary Shares will be issued to the trustee of the Company's Employee Share Ownership Trust and used to satisfy awards and options vesting in 2020 under the Serco Group plc Deferred Bonus Plan and the Serco Group plc Performance Share Plan.

It is expected that admission of these Ordinary Shares will become effective on 6 April 2020. These ordinary shares, which will rank pari passu with the existing Ordinary Shares in issue, will be allotted under the plans listed above.

Following the anticipated admission of these shares, the total number of ordinary shares of 2p each in the capital of the Company in issue will be 1,233,380,637, with each share carrying the right to one vote.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IOEFLFLISSILIII

Talk to a Data Expert

Have a question? We'll get back to you promptly.